Novavax AB

ABActive

Org 5565494019Kungsgatan 109, 753 18 UppsalaResearch and experimental development on natural sciences and engineering · NACE 7210Est. 1997173 employees

Overview Financials People & ownership Related companies

Novavax AB is a Swedish AB based in Uppsala, operating in the Annan naturvetenskaplig och teknisk forskning och utveckling sector. Incorporated in 1997, the company has 173 employees and reported revenue of SEK 524,6M in its latest annual filing.

Revenue 2024

SEK 524,6M

-36% vs 2023

EBITDA margin

20.0%

-48% vs 2023

Equity ratio

94.8%

Financial strength

Net profit 2024

SEK 205,8M

+9% vs 2023

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 524,6M	-36%
EBITDA	SEK 104,8M	-48%
Net profit	SEK 205,8M	+9%
Total assets	SEK 2,7B	-27%
Equity	SEK 2,5B	+10%
Employees	173	—

Contact

Address

Kungsgatan 109, 753 18 Uppsala

Phone

+4618572400

lronnlund@novavax.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Novavax AB?

Novavax AB is registered with Bolagsverket / SCB under Org 5565494019.

What is the revenue of Novavax AB?

Novavax AB reported revenue of SEK 524,6M in 2024.

How many employees does Novavax AB have?

Novavax AB employs 173 people as of the latest annual report.

Who is the CEO of Novavax AB?

Anton Emanuel Vestman is Chief Auditor of Novavax AB, in role since 2022.

Who is the chairman of Novavax AB?

John Anthony Herrmann chairs the board of Novavax AB, in role since 2020.

Where is Novavax AB headquartered?

Novavax AB's registered address is Kungsgatan 109.

Novavax AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Novavax AB

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Novavax AB